Zorilla Research Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Zorilla Research General Information
Description
Developer of predictive computational technology intended for pharmaceutical companies. The company's computational technology predicts problem interactions of drug in the early stages of development for pharmaceutical companies, enabling them to reduce the failure rates of new chemical entities in pharmaceutical research.
Contact Information
Website
zorillaresearch.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Kansas City, MO 64111
- United States
+1 (913) 000-0000
Zorilla Research Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Jun-2023 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-Jun-2014 | Completed | Generating Revenue |
Zorilla Research Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gerald Wyckoff | Founder & Chief Executive Officer & Chief Scientist |